IBDEI2HK ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,42162,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42162,1,3,0)
 ;;=3^Impaired Glucose Tolerance (oral)
 ;;^UTILITY(U,$J,358.3,42162,1,4,0)
 ;;=4^R73.02
 ;;^UTILITY(U,$J,358.3,42162,2)
 ;;=^5019562
 ;;^UTILITY(U,$J,358.3,42163,0)
 ;;=R73.09^^159^2016^15
 ;;^UTILITY(U,$J,358.3,42163,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42163,1,3,0)
 ;;=3^Abnormal Glucose NEC
 ;;^UTILITY(U,$J,358.3,42163,1,4,0)
 ;;=4^R73.09
 ;;^UTILITY(U,$J,358.3,42163,2)
 ;;=^5019563
 ;;^UTILITY(U,$J,358.3,42164,0)
 ;;=R73.9^^159^2016^84
 ;;^UTILITY(U,$J,358.3,42164,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42164,1,3,0)
 ;;=3^Hyperglycemia,Unspec
 ;;^UTILITY(U,$J,358.3,42164,1,4,0)
 ;;=4^R73.9
 ;;^UTILITY(U,$J,358.3,42164,2)
 ;;=^5019564
 ;;^UTILITY(U,$J,358.3,42165,0)
 ;;=R76.11^^159^2016^142
 ;;^UTILITY(U,$J,358.3,42165,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42165,1,3,0)
 ;;=3^Positive PPD
 ;;^UTILITY(U,$J,358.3,42165,1,4,0)
 ;;=4^R76.11
 ;;^UTILITY(U,$J,358.3,42165,2)
 ;;=^5019570
 ;;^UTILITY(U,$J,358.3,42166,0)
 ;;=R79.1^^159^2016^3
 ;;^UTILITY(U,$J,358.3,42166,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42166,1,3,0)
 ;;=3^Abnormal Coagulation Profile
 ;;^UTILITY(U,$J,358.3,42166,1,4,0)
 ;;=4^R79.1
 ;;^UTILITY(U,$J,358.3,42166,2)
 ;;=^5019591
 ;;^UTILITY(U,$J,358.3,42167,0)
 ;;=R82.5^^159^2016^69
 ;;^UTILITY(U,$J,358.3,42167,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42167,1,3,0)
 ;;=3^Elevated Urine Levels of Drug/Meds/Biol Subst
 ;;^UTILITY(U,$J,358.3,42167,1,4,0)
 ;;=4^R82.5
 ;;^UTILITY(U,$J,358.3,42167,2)
 ;;=^5019605
 ;;^UTILITY(U,$J,358.3,42168,0)
 ;;=R82.6^^159^2016^26
 ;;^UTILITY(U,$J,358.3,42168,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42168,1,3,0)
 ;;=3^Abnormal Urine Levels of Subst of Nonmed Source
 ;;^UTILITY(U,$J,358.3,42168,1,4,0)
 ;;=4^R82.6
 ;;^UTILITY(U,$J,358.3,42168,2)
 ;;=^5019606
 ;;^UTILITY(U,$J,358.3,42169,0)
 ;;=R82.7^^159^2016^27
 ;;^UTILITY(U,$J,358.3,42169,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42169,1,3,0)
 ;;=3^Abnormal Urine Microbiological Findings
 ;;^UTILITY(U,$J,358.3,42169,1,4,0)
 ;;=4^R82.7
 ;;^UTILITY(U,$J,358.3,42169,2)
 ;;=^5019607
 ;;^UTILITY(U,$J,358.3,42170,0)
 ;;=R82.8^^159^2016^23
 ;;^UTILITY(U,$J,358.3,42170,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42170,1,3,0)
 ;;=3^Abnormal Urine Cytology/Histology Findings
 ;;^UTILITY(U,$J,358.3,42170,1,4,0)
 ;;=4^R82.8
 ;;^UTILITY(U,$J,358.3,42170,2)
 ;;=^5019608
 ;;^UTILITY(U,$J,358.3,42171,0)
 ;;=R82.90^^159^2016^25
 ;;^UTILITY(U,$J,358.3,42171,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42171,1,3,0)
 ;;=3^Abnormal Urine Findings,Unspec
 ;;^UTILITY(U,$J,358.3,42171,1,4,0)
 ;;=4^R82.90
 ;;^UTILITY(U,$J,358.3,42171,2)
 ;;=^5019609
 ;;^UTILITY(U,$J,358.3,42172,0)
 ;;=R82.91^^159^2016^49
 ;;^UTILITY(U,$J,358.3,42172,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42172,1,3,0)
 ;;=3^Chromoabnormalities of Urine NEC
 ;;^UTILITY(U,$J,358.3,42172,1,4,0)
 ;;=4^R82.91
 ;;^UTILITY(U,$J,358.3,42172,2)
 ;;=^5019610
 ;;^UTILITY(U,$J,358.3,42173,0)
 ;;=R82.99^^159^2016^24
 ;;^UTILITY(U,$J,358.3,42173,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42173,1,3,0)
 ;;=3^Abnormal Urine Findings NEC
 ;;^UTILITY(U,$J,358.3,42173,1,4,0)
 ;;=4^R82.99
 ;;^UTILITY(U,$J,358.3,42173,2)
 ;;=^5019611
 ;;^UTILITY(U,$J,358.3,42174,0)
 ;;=R89.9^^159^2016^19
 ;;^UTILITY(U,$J,358.3,42174,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42174,1,3,0)
 ;;=3^Abnormal Organ/Tissue Specimen Findings,Unspec
 ;;^UTILITY(U,$J,358.3,42174,1,4,0)
 ;;=4^R89.9
 ;;^UTILITY(U,$J,358.3,42174,2)
 ;;=^5019702
 ;;^UTILITY(U,$J,358.3,42175,0)
 ;;=R90.0^^159^2016^98
